- Home
- Search Results
- Page 1 of 1
Search for: All records
-
Total Resources2
- Resource Type
-
00020
- Availability
-
11
- Author / Contributor
- Filter by Author / Creator
-
-
Dordick, Jonathan S. (2)
-
Fraser, Keith (2)
-
Kwon, Paul S. (2)
-
Kwon, Seok-Joon (2)
-
Linhardt, Robert J. (2)
-
Zhang, Fuming (2)
-
Chao, Jie (1)
-
Feroz, Maisha (1)
-
He, Peng (1)
-
Hong, Jung Joo (1)
-
Kim, Domyoung (1)
-
Kizer, Megan E. (1)
-
Kramer, Laura D. (1)
-
Kuo, Lili (1)
-
Oh, Hanseul (1)
-
Ren, Shaokang (1)
-
Rodrigues, Andre L. (1)
-
Seeman, Nadrian C. (1)
-
Wang, Xing (1)
-
Xie, Mo (1)
-
- Filter by Editor
-
-
null (1)
-
& Spizer, S. M. (0)
-
& . Spizer, S. (0)
-
& Ahn, J. (0)
-
& Bateiha, S. (0)
-
& Bosch, N. (0)
-
& Brennan K. (0)
-
& Brennan, K. (0)
-
& Chen, B. (0)
-
& Chen, Bodong (0)
-
& Drown, S. (0)
-
& Ferretti, F. (0)
-
& Higgins, A. (0)
-
& J. Peters (0)
-
& Kali, Y. (0)
-
& Ruiz-Arias, P.M. (0)
-
& S. Spitzer (0)
-
& Spitzer, S. (0)
-
& Spitzer, S.M. (0)
-
(submitted - in Review for IEEE ICASSP-2024) (0)
-
-
Have feedback or suggestions for a way to improve these results?
!
Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher.
Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?
Some links on this page may take you to non-federal websites. Their policies may differ from this site.
-
Abstract SARS-CoV-2 receptor binding domains (RBDs) interact with both the ACE2 receptor and heparan sulfate on the surface of host cells to enhance SARS-CoV-2 infection. We show that suramin, a polysulfated synthetic drug, binds to the ACE2 receptor and heparan sulfate binding sites on the RBDs of wild-type, Delta, and Omicron variants. Specifically, heparan sulfate and suramin had enhanced preferential binding for Omicron RBD, and suramin is most potent against the live SARS-CoV-2 Omicron variant (B.1.1.529) when compared to wild type and Delta (B.1.617.2) variants in vitro. These results suggest that inhibition of live virus infection occurs through dual SARS-CoV-2 targets of S-protein binding and previously reported RNA-dependent RNA polymerase inhibition and offers the possibility for this and other polysulfated molecules to be used as potential therapeutic and prophylactic options against COVID-19.more » « lessFree, publicly-accessible full text available December 1, 2024
-
Kwon, Paul S. ; Ren, Shaokang ; Kwon, Seok-Joon ; Kizer, Megan E. ; Kuo, Lili ; Xie, Mo ; Zhu, Dan ; Zhou, Feng ; Zhang, Fuming ; Kim, Domyoung ; et al ( , Nature Chemistry)null (Ed.)